Abstract: A method of a terminal may comprise: selecting one of a TN base station or NTN base station as a first base station; performing a first access registration procedure between the terminal and a core network through the first base station; identifying whether the core network supports dual-steering, based on a result of the first access registration procedure; in response to identifying that the core network supports dual-steering, performing a second access registration procedure between the terminal and the core network through a second base station other than the first base station among the TN base station or the NTN base station; and in response to a success of the second access registration procedure, performing a multiple access (MA) protocol data unit (PDU) session establishment procedure according to dual-steering through the first base station.

Abstract: Methods of treating and/or preventing disorders mediated by one or more of TNF-?, NF-?B, IKK-?, IKK-?, ATF-2 and p38 kinase by administration of praziquantel, or a pharmaceutically acceptable salt, prodrug, ester or amide thereof. These disorders include inflammatory disorders such as autoimmune diseases.